NCT00024531

Data

{
  "briefSummary": "The purpose of this study is to assess the clinical benefit of Lipitor, a cholesterol-lowering drug, in the treatment of Alzheimer's disease.",
  "completionDate": "2004-08",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": 98,
  "enrollmentType": null,
  "nctId": "NCT00024531",
  "phase": "PHASE2",
  "sponsorId": "institute-for-the-study-of-aging-isoa",
  "startDate": "2000-10",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Effect of the HMG-CoA Reductase Inhibitor Atorvastatin Calcium, Lipitor, in the Treatment of Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00024531"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version